Moderna to Reveal Breakthrough Skin Cancer Vaccine Data Ahead of Investor Meeting

Cambridge, Monday, 21 September 2026.
Moderna will present Phase 3 data for its personalized mRNA skin cancer vaccine at ESMO 2026, marking a historic first for mRNA cancer treatments after cutting recurrence risks.